Nacuity Pharmaceuticals, Inc. — Form D/A
Nacuity Pharmaceuticals, Inc. of FORT WORTH, TX, a company, filed a Form D amendment with the SEC on 2022-01-03. The offering totals $17.4M, of which $11.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-01-03
- Form: D/A
- Accession: 0001690279-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $17.4M
- Amount sold: $11.6M
- Remaining: $5.8M
- Minimum investment: $10K
- Investors: 144
- Date of first sale: 2021-03-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-394011
Issuer
- Name: Nacuity Pharmaceuticals, Inc.
- CIK: 0001690279
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: FORT WORTH CLUB BLDG., FORT WORTH, TX, 76102
- Phone: 817-336-3000
Officers, directors & promoters (23)
| Name | Role | Location |
|---|
| Robert Ruffolo | Director | Boston, MA |
| Robin Steel | Director | Fort Worth, TX |
| Michael Wall | Executive Officer | Fort Worth, TX |
| Robin Steele | Director | Fort Worth, TX |
| David Wohlberg | Director | Fort Worth, TX |
| David Wohlberg | Executive Officer | Fort Worth, TX |
| Rusty Kelley | Director | Fort Worth, TX |
| Gerald Cagle | Director | Fort Worth, TX |
| Jami Kern | Executive Officer | Fort Worth, TX |
| Benjamin Yerxa | Director | Fort Worth, TX |
| Emmett Cunningham, Jr. | Director | Fort Worth, TX |
| Halden Conner | Director | Fort Worth, TX |
| Halden Conner | Executive Officer | Fort Worth, TX |
| Charles Lieser | Executive Officer | Fort Worth, TX |
| Isaac Michael Blech | Director | New York, NY |
| Charles Michael Lieser | Executive Officer | Fort Worth, TX |
| G. Michael Wall, Ph.D. | Executive Officer | Fort Worth, TX |
| Dr. Gerald D Cagle | Director | Fort Worth, TX |
| David J Wohlberg | Director | Los Angeles, CA |
| William Halden Conner | Director | Fort Worth, TX |
| William Halden Conner | Executive Officer | Fort Worth, TX |
| Richard Michael Chin, M.D. | Director | San Francisco, CA |
| Sanford J Hillsberg | Director | Los Angeles, CA |
Other filings by this issuer (5)
More